This Has Won 99.1% Of Trades Over 3 Years
Video reveals the most powerful trade you’ve NEVER heard of. Released every Tuesday, it could DOUBLE your money by Friday.

In past 3 years, it’s won 321 out of 324 of these trades, with the majority making 100%+ every 3-10 days.

See how a simple 10-minute trade on Tue could double your money by Fri.

Watch Video Now For Full Details.
>>>
Alexander R. Mackenzie, insider at Pfizer

Alexander R. Mackenzie Insider Information

EVP of Pfizer
Rod MacKenzie, PhD, is Chief Development Officer and Executive Vice President for Pfizer. Rod leads the Global Product Development organization, which is responsible for the clinical development and advancement of Pfizer’s pipeline of innovative medicines in inflammation and immunology, internal medicine, hospital, oncology and rare disease, as well as regulatory affairs in support of Pfizer’s R&D pipeline and portfolio of marketed therapies. He serves on the Portfolio Strategy and Investment Committee, which focuses on maximizing the return on R&D investment across the Pfizer portfolio, and is a member of Pfizer’s Executive Leadership Team.

Rod joined Pfizer in Sandwich, UK as a Research Scientist and conducted medicinal chemistry research in the cardiovascular, GI, Sexual Health, Urology and Allergy & Respiratory diseases. Rod is the co-inventor of darifenacin (Enablex™).

Rod has held numerous leadership positions at Pfizer, including Head of PharmaTherapeutics Research and Development where he oversaw the Cardiovascular & Metabolic Diseases, Pain & Sensory Disorders and Neuroscience Research Units and was responsible for all medicinal chemistry at Pfizer, as well as Small Molecule Pharmaceutical Sciences, Pharmacokinetics, Dynamics & Metabolism and Comparative Medicine. He also served as Site Director of the Groton, Connecticut laboratories, Pfizer’s largest global R&D facility. Prior to this role, Rod held a series of research leadership positions, including Senior Vice President and Head of Worldwide Research, Head of Discovery Chemistry in Sandwich, U.K., Head of the Discovery Technology Center in Cambridge, Massachusetts, Head of Discovery Research in Ann Arbor, Michigan, and Head of Drug Safety R&D.

Rod represents Pfizer on the Board of Directors for ViiV Healthcare, a global specialist HIV company established by GlaxoSmithKline and Pfizer to deliver advances in treatment and care for people living with HIV. He also represents Pfizer as Vice Chair on the Board of Directors for TransCelerate, a non-profit organization with a mission to collaborate across the biopharmaceutical research and development community to improve the health of people around the world by accelerating and enhancing the research and development of innovative new therapies, as well as on the Board of Directors for The National Health Council, an organization that brings together all segments of the health community to forge consensus and drive patient-centered health policy. Rod is also a member of the Executive Committee for Clinical Trials Transformation Initiative, a public-private partnership co-founded by FDA and Duke University to develop and drive practices that will increase the quality and efficiency of clinical trials. In recognition of his long-time advocacy for the advancement of women in the healthcare industry, Rod was named Healthcare Businesswomen’s Association 2020 Honorable Mentor.

Rod graduated from the University of Glasgow with a 1st Class Honors degree in chemistry and completed his PhD at Imperial College, London. He was awarded a NATO Postdoctoral Research Fellowship and spent two years at Columbia University, New York working in the area of molecular recognition with Professor W.C. Still.

What is Alexander R. Mackenzie's net worth?

The estimated net worth of Alexander R. Mackenzie is at least $4.19 million as of June 20th, 2019. Dr. Mackenzie owns 80,094 shares of Pfizer stock worth more than $4,189,717 as of July 4th. This net worth estimate does not reflect any other assets that Dr. Mackenzie may own. Learn More about Alexander R. Mackenzie's net worth.

How do I contact Alexander R. Mackenzie?

The corporate mailing address for Dr. Mackenzie and other Pfizer executives is 235 EAST 42ND STREET, NEW YORK NY, 10017. Pfizer can also be reached via phone at (212) 733-2323. Learn More on Alexander R. Mackenzie's contact information.

Has Alexander R. Mackenzie been buying or selling shares of Pfizer?

Alexander R. Mackenzie has not been actively trading shares of Pfizer during the last quarter. Most recently, 0 shares of BMO Capital Markets stock in a transaction that occurred on Monday, July 4th. Learn More on Alexander R. Mackenzie's trading history.

Who are Pfizer's active insiders?

Pfizer's insider roster includes Ronald Blaylock (Director), Loretta Cangialosi (VP), William Carapezzi, Jr. (EVP), Frank D'Amelio (EVP), Jennifer Damico (SVP), Jennifer Damico (SVP), Rady Johnson (Insider), Douglas Lankler (EVP), Alexander Mackenzie (EVP), Laurie Olson (Insider), Ian Read (CEO), Dawn Rogers (EVP), Sally Susman (Insider), and John Young (Insider). Learn More on Pfizer's active insiders.

Are insiders buying or selling shares of Pfizer?

In the last year, insiders at the biopharmaceutical company sold shares 8 times. They sold a total of 276,647 shares worth more than $14,190,373.18. The most recent insider tranaction occured on June, 7th when SVP Jennifer B Damico sold 4,218 shares worth more than $227,603.28. Insiders at Pfizer own 0.1 % of the company. Learn More about insider trades at Pfizer.

Information on this page was last updated on 6/7/2022.

Alexander R. Mackenzie Insider Trading History at Pfizer

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/2/2021Sell41,360$54.26$2,244,193.60View SEC Filing Icon  
6/20/2019Sell30,000$44.00$1,320,000.0080,094View SEC Filing Icon  
4/1/2019Sell15,000$42.83$642,450.00124,994View SEC Filing Icon  
8/3/2018Sell25,642$39.51$1,013,115.42127,954View SEC Filing Icon  
12/15/2017Sell6,750$37.00$249,750.00103,458View SEC Filing Icon  
11/1/2017Sell14,700$35.30$518,910.00117,432View SEC Filing Icon  
10/2/2017Sell7,350$35.65$262,027.50117,432View SEC Filing Icon  
9/1/2017Sell7,350$34.00$249,900.00124,774View SEC Filing Icon  
8/31/2017Sell7,350$34.00$249,900.00132,124View SEC Filing Icon  
8/7/2017Sell15,000$33.50$502,500.00151,474View SEC Filing Icon  
See Full Table

Alexander R. Mackenzie Buying and Selling Activity at Pfizer

This chart shows Alexander R Mackenzie's buying and selling at Pfizer by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pfizer Company Overview

Pfizer logo
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Read More

Today's Range

Now: $52.31
Low: $51.25
High: $52.37

50 Day Range

MA: $50.66
Low: $46.53
High: $53.99

2 Week Range

Now: $52.31
Low: $38.93
High: $61.71

Volume

16,143,200 shs

Average Volume

29,302,072 shs

Market Capitalization

$293.51 billion

P/E Ratio

12.00

Dividend Yield

3.06%

Beta

0.73
This Has Won 99.1% Of Trades Over 3 Years
Video reveals the most powerful trade you’ve NEVER heard of. Released every Tuesday, it could DOUBLE your money by Friday.

In past 3 years, it’s won 321 out of 324 of these trades, with the majority making 100%+ every 3-10 days.

See how a simple 10-minute trade on Tue could double your money by Fri.

Watch Video Now For Full Details.
>>>